SunLink Ebitda from 2010 to 2025

SSY Stock  USD 1.05  0.06  6.06%   
SunLink Health EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA is likely to outpace its year average in 2025. During the period from 2010 to 2025, SunLink Health EBITDA regression line of annual values had r-squared of  0.33 and arithmetic mean of  708,187. View All Fundamentals
 
EBITDA  
First Reported
1985-09-30
Previous Quarter
-881 K
Current Value
-688 K
Quarterly Volatility
17 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check SunLink Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SunLink Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 M, Interest Expense of 855 or Total Revenue of 27.7 M, as well as many indicators such as Price To Sales Ratio of 0.41, Dividend Yield of 0.0 or PTB Ratio of 2.54. SunLink financial statements analysis is a perfect complement when working with SunLink Health Valuation or Volatility modules.
  
Check out the analysis of SunLink Health Correlation against competitors.

Latest SunLink Health's Ebitda Growth Pattern

Below is the plot of the Ebitda of SunLink Health Systems over the last few years. It is SunLink Health's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in SunLink Health's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

SunLink Ebitda Regression Statistics

Arithmetic Mean708,187
Geometric Mean1,544,317
Coefficient Of Variation360.09
Mean Deviation2,140,688
Median808,000
Standard Deviation2,550,103
Sample Variance6.5T
Range8M
R-Value(0.57)
Mean Square Error4.7T
R-Squared0.33
Significance0.02
Slope(306,053)
Total Sum of Squares97.5T

SunLink Ebitda History

2025-387.3 K
2024-407.7 K
2023-453 K
2022-1.7 M
2021-3.8 M
20203.2 M
20191.2 M

About SunLink Health Financial Statements

SunLink Health investors use historical fundamental indicators, such as SunLink Health's Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in SunLink Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-407.7 K-387.3 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for SunLink Stock Analysis

When running SunLink Health's price analysis, check to measure SunLink Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SunLink Health is operating at the current time. Most of SunLink Health's value examination focuses on studying past and present price action to predict the probability of SunLink Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SunLink Health's price. Additionally, you may evaluate how the addition of SunLink Health to your portfolios can decrease your overall portfolio volatility.